$IVF Income Statement | Understand Stock

$IVF

$0.54 -$0.02 (3.6%) Close

$IVF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Clinic Revenue
Product
Product Revenue
License Revenue
License
Total revenue

Operating expenses:
Cost of revenue
Cost of services
Cost of goods sold
Depreciation
Total cost of revenue
Gross profit
Selling, general and administrative expenses
Research and development expenses
Impairment of intangible assets
Loss on disposal of fixed assets
Depreciation and amortization
Total operating expenses

Loss from operations
Other income (expense):
Loss from equity method joint ventures
Gain from equity method joint ventures
Impairment from equity method joint venture
Impairment from equity method joint ventures
Gain on changes in fair value
Gain on lease termination
Extinguishment loss
Interest income
Loss on issuance of warrants
Gain on settlement of liability (Note 18)
Interest expense
Foreign currency exchange loss
Total other income (expenses)

Net loss before income taxes
Provision (benefit) for income taxes
Net loss from continuing operations
Loss on disposal of NTI (Note 4)
Loss on discontinued operations of NTI (Note 4)
Net loss
Common stock warrants deemed dividends
Preferred stock dividends and deemed dividends
Net loss attributable to common shareholders
Net loss from continuing operations per common share:
Basic
Diluted
Net loss from discontinued operations per common share:
Basic
Diluted
Net loss per common share:
Basic
Diluted
Weighted average number of common shares outstanding:
Basic
Diluted

Comments